FCCC LOGO Faculty Publications
Benson A , Venook AP , Al-Hawary MM , Cederquist L , Chen YJ , Ciombor KK , Cohen S , Cooper HS , Deming D , Engstrom PF , Grem JL , Grothey A , Hochster HS , Hoffe S , Hunt S , Kamel A , Kirilcuk N , Krishnamurthi S , Messersmith WA , Meyerhardt J , Mulcahy MF , Murphy JD , Nurkin S , Saltz L , Sharma S , Shibata D , Skibber JM , Sofocleous CT , Stoffel EM , Stotsky-Himelfarb E , Willett CG , Wuthrick E , Gregory KM , Freedman-Cass DA
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw. 2018 Jul;16(7) :852-871
Back to previous list
Abstract
The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.
Notes
Benson, Al B., III Venook, Alan P. Al-Hawary, Mahmoud M. Cederquist, Lynette Chen, Yi-Jen Ciombor, Kristen K. Cohen, Stacey Cooper, Harry S. Deming, Dustin Engstrom, Paul F. Grem, Jean L. Grothey, Axel Hochster, Howard S. Hoffe, Sarah Hunt, Steven Kamel, Ahmed Kirilcuk, Natalie Krishnamurthi, Smitha Messersmith, Wells A. Meyerhardt, Jeffrey Mulcahy, Mary F. Murphy, James D. Nurkin, Steven Saltz, Leonard Sharma, Sunil Shibata, David Skibber, John M. Sofocleous, Constantinos T. Stoffel, Elena M. Stotsky-Himelfarb, Eden Willett, Christopher G. Wuthrick, Evan Gregory, Kristina M. Freedman-Cass, Deborah A. 1540-1413 J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.